114 related articles for article (PubMed ID: 26665182)
61. Modular expression analysis reveals functional conservation between human Langerhans cells and mouse cross-priming dendritic cells.
Artyomov MN; Munk A; Gorvel L; Korenfeld D; Cella M; Tung T; Klechevsky E
J Exp Med; 2015 May; 212(5):743-57. PubMed ID: 25918340
[TBL] [Abstract][Full Text] [Related]
62. Functional analysis of HPV-like particle-activated Langerhans cells in vitro.
Yan L; Woodham AW; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():333-50. PubMed ID: 25348318
[TBL] [Abstract][Full Text] [Related]
63. Molecular analysis of human papillomavirus virus-like particle activated Langerhans cells in vitro.
Woodham AW; Raff AB; Da Silva DM; Kast WM
Methods Mol Biol; 2015; 1249():135-49. PubMed ID: 25348303
[TBL] [Abstract][Full Text] [Related]
64. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.
Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N
EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878
[TBL] [Abstract][Full Text] [Related]
65. The origins and functions of dendritic cells and macrophages in the skin.
Malissen B; Tamoutounour S; Henri S
Nat Rev Immunol; 2014 Jun; 14(6):417-28. PubMed ID: 24854591
[TBL] [Abstract][Full Text] [Related]
66. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial.
Salazar AM; Erlich RB; Mark A; Bhardwaj N; Herberman RB
Cancer Immunol Res; 2014 Aug; 2(8):720-4. PubMed ID: 24801836
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression.
Woodham AW; Raff AB; Raff LM; Da Silva DM; Yan L; Skeate JG; Wong MK; Lin YG; Kast WM
J Immunol; 2014 May; 192(10):4748-57. PubMed ID: 24719459
[TBL] [Abstract][Full Text] [Related]
68. Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.
Da Silva DM; Movius CA; Raff AB; Brand HE; Skeate JG; Wong MK; Kast WM
Virology; 2014 Mar; 452-453():279-86. PubMed ID: 24606705
[TBL] [Abstract][Full Text] [Related]
69. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
70. Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice.
Domingos-Pereira S; Decrausaz L; Derré L; Bobst M; Romero P; Schiller JT; Jichlinski P; Nardelli-Haefliger D
Mucosal Immunol; 2013 Mar; 6(2):393-404. PubMed ID: 22968420
[TBL] [Abstract][Full Text] [Related]
71. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.
Rositch AF; Koshiol J; Hudgens MG; Razzaghi H; Backes DM; Pimenta JM; Franco EL; Poole C; Smith JS
Int J Cancer; 2013 Sep; 133(6):1271-85. PubMed ID: 22961444
[TBL] [Abstract][Full Text] [Related]
72. Epithelial cell responses to infection with human papillomavirus.
Stanley MA
Clin Microbiol Rev; 2012 Apr; 25(2):215-22. PubMed ID: 22491770
[TBL] [Abstract][Full Text] [Related]
73. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
[TBL] [Abstract][Full Text] [Related]
74. Changing views of the role of Langerhans cells.
Romani N; Brunner PM; Stingl G
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):872-81. PubMed ID: 22217741
[TBL] [Abstract][Full Text] [Related]
75. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans.
Caskey M; Lefebvre F; Filali-Mouhim A; Cameron MJ; Goulet JP; Haddad EK; Breton G; Trumpfheller C; Pollak S; Shimeliovich I; Duque-Alarcon A; Pan L; Nelkenbaum A; Salazar AM; Schlesinger SJ; Steinman RM; Sékaly RP
J Exp Med; 2011 Nov; 208(12):2357-66. PubMed ID: 22065672
[TBL] [Abstract][Full Text] [Related]
76. Langerhans cells are precommitted to immune tolerance induction.
Shklovskaya E; O'Sullivan BJ; Ng LG; Roediger B; Thomas R; Weninger W; Fazekas de St Groth B
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):18049-54. PubMed ID: 22006331
[TBL] [Abstract][Full Text] [Related]
77. Cutting edge: virus selectively primes human langerhans cells for CD70 expression promoting CD8+ T cell responses.
van der Aar AM; de Groot R; Sanchez-Hernandez M; Taanman EW; van Lier RA; Teunissen MB; de Jong EC; Kapsenberg ML
J Immunol; 2011 Oct; 187(7):3488-92. PubMed ID: 21880979
[TBL] [Abstract][Full Text] [Related]
78. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Okada H; Kalinski P; Ueda R; Hoji A; Kohanbash G; Donegan TE; Mintz AH; Engh JA; Bartlett DL; Brown CK; Zeh H; Holtzman MP; Reinhart TA; Whiteside TL; Butterfield LH; Hamilton RL; Potter DM; Pollack IF; Salazar AM; Lieberman FS
J Clin Oncol; 2011 Jan; 29(3):330-6. PubMed ID: 21149657
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
